DATED 15 May 2019 BicycleTX Ltd and Dr Kevin Lee
DATED 15 May 2019
BicycleTX Ltd
and
Xx Xxxxx Xxx
STATEMENT OF MAIN TERMS AND CONDITIONS OF
EMPLOYMENT
THIS AGREEMENT is made on 15 May 2019
BETWEEN:
(1) BICYCLETX LIMITED a company incorporated under the laws of England and Wales (Company Number 11036101) whose registered office is at Building 900, Babraham Research Xxxxxx, Xxxxxxxxx, XX00 0XX, Xxxxxx Xxxxxxx (the “Company”); and
(2) XX XXXXX XXX of 00 Xxxx Xxxxxx, Xxxxx Xxxxxxxxx, Xxxxxxxxx XX00 0XX (the “Employee”).
IT IS AGREED as follows:
1. COMMENCEMENT OF EMPLOYMENT
1.1 Your employment commenced on 02 September 2015 and shall continue unless and until either party gives notice to the other in accordance with paragraph 11 below. No employment with a previous employer is deemed to be continuous with your employment with the Company.
1.2 This Agreement shall take effect on (and is conditional upon) an initial public offering of American depositary shares representing ordinary shares in the capital of the Company occurring on or before 30 June 2019 and, once effective, replaces all and any previous employment agreements between you and the Company including (without limitation) your offer letter dated 30 June 2015, your statement of main terms and conditions of employment dated 2 September 2015 and your statement of main terms and conditions of employment dated 1 August 2018.
1.3 You warrant that by entering into this Agreement or any other arrangements with the Company you will not be in breach of or subject to any express or implied terms of any contract with, or other obligation to, any third party binding on you, including, without limitation, any notice period or the provisions of any restrictive covenants or confidentiality obligations arising out of any employment with any other employer or former employer.
1.4 You warrant that you have the right to work in the United Kingdom and you agree to provide to the Company copies of all relevant documents in this respect at the request of the Company. If at any time during the course of this Agreement you cease to have the right to work in the United Kingdom the Company may immediately terminate your employment without payment of compensation.
2. JOB TITLE
2.1 You shall serve as Chief Executive Officer (“CEO”) reporting to the board of directors (“the Board”). The nature of the Company’s business may result in changes occurring to the content of your role from time to time. You may also be required to carry out such additional or alternative tasks as may from time to time be reasonably required of you consistent with your executive level and job title, provided that these do not fundamentally change or undermine your position.
2.2 You shall faithfully and diligently perform such duties as you are required to undertake from time to time and exclusively devote the whole of your working time, skills, ability and attention to the business of the Company and use all reasonable endeavours to promote the interests and reputation of the Company.
2.3 Your appointment as a director of the Company is a condition of this Agreement, and in the event that you resign your directorship the Company will treat this as a resignation of your employment.
3. PLACE OF WORK
3.1 The Company’s offices is at Xxxxxxxx 000, Xxxxxxxx Xxxxxxxx Xxxxxx, Xxxxxxxxx, XX or such other location as the Company may reasonably determine. The CEO position will require extensive international travel on business.
3.2 Relocation:
We understand that as a result of your current employment you currently have residences in the Boston area of the United States and the Cambridge area of the UK. Since you intend to relocate from your Boston area residence, you may be able to benefit from certain relocation personal tax allowances permitted by HR Revenue and Customs. The current maximum allowance for tax-free relocation is £8,000, but this may be limited or not offered for higher rate income tax payers. You should take independent advice on your tax affairs relating to your employment by the Company and your relocation arrangements. The Company will offer an allowance for relocation of you and your family and your personal possessions to a location to be a reasonable commuting distance from the Company’s Cambridge facility as follows:
(a) the maximum aggregate entitlement to reimbursable relocation associated payments under (b) below will be £10,000;
(b) in order for you to relocate fully from the Boston area to the Cambridge area the Company will:
i. reimburse the cost of transport of personal possessions from your residential address in the United States to your accommodation in the Cambridge area;
ii. reimburse the costs associated with your relocation in respect of any relocation agent, estate agent, legal fees and stamp duty relating to property purchase or rental and fitting out of such accommodation to a standard appropriate for you and your family;
iii. reimburse the cost of initial and annual personal tax advice with Xxxxx Xxxxxxxx or a similar firm of your choosing;
such reimbursements to be made within 30 days of presentation of valid receipts for such expenses; and
(c) any relocation payments made under (b) above will be repayable by you to the Company if you should leave employment of the Company of your own volition within 24 months of the commencement of this Agreement and will be deductible from final salary at the discretion of the Company.
4. REMUNERATION
4.1 Your salary will be USD575,000 per annum paid monthly in arrears (less statutory and voluntary deductions) (“Salary”). Salary will be converted to GBP and paid in GBP based on the USD/GBP Bank of England daily spot exchange rate applicable on the date of this Agreement, with the exchange rate being revised according to the prevailing Bank of England daily spot exchange rate applicable on 1 January of each year. Your Salary will be reviewed annually in accordance with the Company’s practices from time to time (which is expected to be by the end of the first quarter of each year). You will be notified in writing of any changes to your Salary or benefits.
4.2 You agree that the Company may deduct from the Salary or any other sum due to you (including any pay in lieu of notice) any amounts due to the Company including, without limitation, any overpayment of salary, loan or advance.
4.3 For the purposes of this Agreement your earned salary shall mean the proportion of your Salary earned by and due to you in each calendar year of employment with the Company (“Earned Salary”).
4.4 Retention Bonus:
You have previously received a cash bonus relating to security of continuation of your service as an employee in the amount of £100,000 (the “Retention Bonus”). In the event that you give notice to terminate your employment with the Company at any time before 1 August 2020 you will be obliged to repay the Retention Bonus, net of statutory applicable tax and National Insurance deductions. In this event the Company shall have the right to deduct such owed element of the Retention Bonus from your Salary or other bonus payments that may fall due.
4.5 Annual Performance Bonuses:
You will be eligible to participate in the Company’s discretionary annual performance related bonus scheme to a maximum value of 50% of your Earned Salary in relation to your performance against agreed annual corporate and personal performance objectives as set out below (the “Annual Performance Bonus”). That is, if the remuneration committee of the Board (the “Remuneration Committee”) determines that you have completed all such corporate and personal objectives to its satisfaction in a given year, your bonus would be 50% of your Earned Salary in that year, excluding any other bonuses in this offer. Such bonus may be payable in cash or, in whole or in part, in share options in the Company’s parent company, Bicycle Therapeutics Limited (“BTL”), as agreed by you and the Remuneration Committee (and in the case of share options with the appropriate HMRC valuation process (if required by the Remuneration Committee) and board approval so as to be compliant with BTL’s share option plan rules) with due consideration for the operational requirements of the Company at that time in your role as CEO.
Any Annual Performance Bonus paid will not be pensionable and are subject to statutory applicable tax and National Insurance deductions. Performance will be assessed by the Remuneration Committee at the end of each calendar year, against annual corporate and personal performance objectives agreed between you and the Board at the start of each calendar year, with any such bonus being payable in the first quarter of the following year. Qualification for your Annual Performance Bonus will require that you are employed by the Company (and have not served notice of termination of your employment to the Company) on 31 December of the year to which your bonus entitlement applies.
4.6 Shareholder Value Realisation Bonus:
In this paragraph, defined terms have the meaning set out in the Schedule to this agreement unless otherwise stated.
(a) To align your interests with the interests of investors and to incentivise you to work towards a Sale Event in the short to medium term, you may be eligible for a cash bonus (“SVR Bonus”) subject to the terms set out below.
(b) If a Sale Event occurs on or before 1 August 2022 during your CEO leadership which the Remuneration Committee considers, in its sole discretion, you have been instrumental in achieving, you may be paid a SVR Bonus calculated in accordance with the following
formula:
A = B x C
Where:
A means the amount of the SVR Bonus;
B means the Sale Event Proceeds; and
C means the Relevant Percentage depending on the amount of the Sale Event Proceeds as set out in the table below:
|
Sale Event Proceeds |
|
Relevant Percentage to be applied |
|
|
Less than or equal to £450 million |
|
0.5 |
% |
|
More than £450 million but less than or equal to £1 billion |
|
0.75 |
% |
|
More than £1 billion |
|
1 |
% |
(c) To the extent that the Sale Event Proceeds consist of retained, deferred or conditional consideration (including, for the avoidance of doubt, amounts retained in escrow) then you agree that your SVR Bonus will be paid in tranches at the same time and in the same proportions as payments received by the selling Shareholders and/or the Company or BTL (as the case may be). If, and to the extent that, the amounts of such retained, deferred and /or conditional consideration payable to the selling Shareholders and/or the Company or BTL (as the case may be) are reduced and/or extinguished then the corresponding amount of your SVR Bonus shall be reduced and/or extinguished in the same proportion(s).
(d) If more than one Sale Event occurs before the fourth anniversary of this Agreement, you will be entitled to an SVR Bonus calculated on the Sale Event Proceeds generated at each Sale Event (and not based on aggregating such proceeds across all Sale Events).
(e) Your entitlement to the SVR Bonus is conditional on you being an employee of and in good standing (as assessed by the Remuneration Committee in its sole discretion) with the Company and not under notice of termination of employment on the Sale Event Date.
(f) Any SVR Bonus paid will be paid as soon as reasonably practicable following the Sale Event subject to statutory applicable tax and National Insurance deductions. Any SVR Bonus will not be pensionable.
(g) For the avoidance of doubt the SVR Bonus is in addition to any Annual Performance Bonuses you may receive.
(h) In the event of any dispute about the SVR Bonus, the Remuneration Committee’s
decision shall be final and binding on all parties.
5 BENEFITS
5.1 The Company currently operates a personal pension plan provided by Scottish Widows Group. The Company will pay a sum equivalent to 12% of your basic annual earned salary into a personal pension plan selected by the Company. You may make additional contributions if you wish, but this is not mandatory.
5.2 The Company currently operates a private healthcare scheme and subject to acceptance by the insurer on reasonable terms, you will be entitled to join.
5.3 The Company operate a death in service scheme which you automatically join upon commencement of employment.
5.4 Further details regarding benefits will be provided upon commencement of your employment. The Company reserves the right to replace or supplement any or all of the scheme(s) referred to in this paragraph 5, or to amend them at any time without compensation, provided that equivalent scheme(s) providing a similar level of benefit are put in place.
6 EXPENSES
6.1 The Company shall reimburse all reasonable out of pocket expenses properly incurred by you in the performance of the duties under this Agreement including travelling, subsistence and entertainment expenses provided you follow the Company’s guidelines/allowances in force at the relevant time and provided that you shall, where reasonably practicable, provide the Company with vouchers, invoices or such other evidence of such expenses as the Company may reasonably require.
7 HOURS OF WORK
7.1 Your normal working hours are Monday to Friday from 9.00 am to 5.30 pm on each working day with one hour for lunch. From time to time you may be required to work such other hours as shall be reasonably necessary for you to perform your duties for which no further remuneration is payable.
7.2 By entering into this Agreement you confirm, that in your capacity as Chief Executive Officer you may choose or determine the duration of your working time and the working time limits set out in part II of the Working Time Regulations 1998 do not apply to you.
8 HOLIDAYS
8.1 In addition to the usual public holidays you will be entitled to 25 working days paid holiday in each calendar year. The holiday will accrue on a pro rata basis throughout each calendar year.
8.2 Holidays may only be taken at such time or times as are approved beforehand by the Board or any director that the Board may delegate, such approval not to be unreasonably withheld or delayed. You must give reasonable notice of proposed holiday dates by e-mailing the chairman of the Board (the “Chairman”) or delegated director in advance, for approval.
8.3 The holiday year runs from January to December. With the agreement of the Chairman (or delegated director), you may carry forward up to 5 days of untaken holiday into the next holiday year. Any carried over holiday must be taken by the end of March of the following calendar year or will be forfeited and no payment will be made in respect of any days so forfeited. You will not
generally be permitted to take more than 10 days holiday at any one time.
8.4 Upon termination of your employment you will receive pay in lieu of accrued but untaken holiday. The Company may deduct an appropriate sum in respect of days taken in excess of your pro rata entitlement from your final remuneration on the basis that one day’s holiday will be calculated as 1/260ths of your basic annual salary.
8.5 In the event that notice of termination of this Agreement is served by either party, the Company may require you to take any outstanding holiday during this notice period.
9 SICKNESS AND OTHER ABSENCE
9.1 If you are unable to attend at work by reason of sickness or injury or any unauthorised reason you must inform the Company as soon as possible on the first day of absence (and in any event not later than 11.00 am on the first day of absence) and, in the case of absence of uncertain duration, you must keep the Company regularly informed of your continued absence and your likely date of return. You are expected to observe this rule very strictly since failure to do so will entitle the Company to stop payment in respect of each day you fail to notify the Company.
9.2 If your absence, due to sickness or injury, is for less than seven (7) days, on your return to work you are required to immediately complete a self-certification form available from the Company. If your absence continues for more than seven (7) consecutive days (whether or not working days) you must provide the Company with a doctor’s certificate from the seventh consecutive day of sickness or injury. This doctor’s certificate must be provided to the Company promptly following the seventh consecutive day of absence. If illness continues after the expiry of the first certificate, further certificates must be provided promptly to cover the whole period of absence.
9.3 Subject to your compliance with the Company’s sickness absence procedures (as amended from time to time), the Company may in its sole and absolute discretion pay full salary and contractual benefits during any period of absence due to sickness or injury for up to an aggregate of 3 months in any fifty-two (52) week period (whether such absence is continuous or intermittent in any calendar year). Such payment shall be inclusive of any statutory sick pay due in accordance with applicable legislation in force at the time of absence. The Company may, in its sole and absolute discretion, extend the period of allowance in an individual case if the circumstances so justify. Thereafter, the Company shall pay statutory sick pay or equivalent benefit to which you may be entitled subject to your compliance with the appropriate rules.
9.4 Whether absent from work or not, you may be, but only on reasonable grounds, required to undergo a medical examination by a Company doctor and your consent will be sought for a report to be sent to the Company.
9.5 The payment of sick pay in accordance with this paragraph 9 is without prejudice to the Company’s right to terminate this Agreement prior to the expiry of your right to payments.
9.6 In the event you are incapable of performing your duties by reason of injuries sustained wholly or partly as a result of a third party’s actions all payments made to you by the Company as salary or sick pay shall to the extent that compensation is recoverable from that third party constitute loans to you and shall be due and owing when and to the extent that you recover compensation for loss of earnings from the third party.
10 GARDEN LEAVE
10.1 The Company reserves the right to require that you do not attend the Company premises (or the
premises of any other member of the Company’s group (a “Group Company”)) or have contact with other staff or clients of the Company or any Group Company for such period as the Company feels is reasonable. This includes any period or part of any period during which you are serving notice as set out in paragraph 11 below (referred to in this Agreement as “Garden Leave”).
10.2 You will continue to owe all other duties and obligations (whether express or implied including fidelity and good faith) during such period of Garden Leave. During any period of Garden Leave you shall continue to receive full pay and benefits.
10.3 In the event that you are placed on Garden Leave the Company is entitled to provide you with no duties. By placing you on Garden Leave, the Company will not be in breach of this Agreement or any implied duty of any kind whatsoever nor will you have any claim against the Company in respect of any such action.
10.4 During any period of Garden Leave you will remain readily contactable and available for work save when on paid holiday taken in accordance with paragraph 8. In the event that you are not available for work having been requested by the Company to do so, you will, notwithstanding any other provision of this Agreement, forfeit any right to salary and contractual benefits.
10.5 During any period of Garden Leave the Company may require you to deliver up any Confidential Information or property of the Company or any Group Company and upon instruction, delete any emails, spreadsheets or other Confidential Information and you will confirm your compliance with this paragraph 10.5 in writing if requested to do so by the Company.
10.6 During any period of Garden Leave the Company may require you to take any outstanding holiday entitlement.
11 NOTICE
11.1 Without prejudice to the Company’s right to summarily terminate your employment in accordance with paragraph 11.3 below and your right to summarily terminate your employment for Good Reason in accordance with paragraph 11.4 below, either you or the Company may terminate your employment by giving to the other not less than three months’ notice in writing.
11.2 The Company reserves the right in its sole and absolute discretion to give written notice to terminate your employment forthwith and to make a payment to you in lieu of salary and the benefits set out in paragraph 5 of this Agreement for all or any unexpired part of the notice period. For the avoidance of doubt, any payment in lieu made pursuant to this paragraph 11.2 will not include any element in relation to any payment in respect of (i) any Annual Performance Bonus or SVR Bonus (unless you are eligible to receive it under the terms of paragraph 4.6 above) and (ii) any holiday entitlement that would have otherwise accrued during the period for which the payment in lieu is made. For the further avoidance of doubt, if the Company elects to make a Payment in Lieu after notice of termination has been given by you, this will not constitute a termination by the Company without Cause for the purposes of clauses 11.7 and 11.8 below.
11.3 The Company may summarily terminate your employment hereunder (without notice) for Cause. For purposes of this Agreement, “Cause” shall mean where you:
(a) commit gross misconduct which includes, but is not limited to, dishonesty, fraud, theft, being under the influence of alcohol or drugs at work, causing actual or threatening physical harm and causing damage to Company property;
(b) commit a material breach or non-observance of your duties or any of the provisions of this Agreement or materially fail to observe the lawful directions of the Company;
(c) are convicted of a criminal offence (other than an offence under the road traffic legislation in the United Kingdom or elsewhere for which a non-custodial sentence is imposed);
(d) act in a manner which in the reasonable opinion of the Company, brings the Company into disrepute or otherwise prejudices or is in the reasonable opinion of the Company considered likely to prejudice the reputation of the Company;
(e) in the reasonable opinion of the Company, are guilty of any serious negligence in connection with or affecting the business or affairs of the Company;
(f) are unfit to carry out the duties hereunder because of sickness, injury or otherwise for an aggregate period of 26 weeks in any fifty-two (52) week period even if, as a result of such termination, you would or might forfeit any entitlement to benefit from sick pay under paragraph 9.3 above.
Any delay or forbearance by the Company in exercising any right of termination in accordance with paragraph 11.3 above will not constitute a waiver of such right.
11.4 You may summarily terminate your employment hereunder at any time (without notice) for Good Reason after complying with the Good Reason Process. For purposes of this Agreement, “Good Reason” shall mean that you have complied with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events: (i) a material diminution in your responsibilities, authority or duties; (ii) a material diminution in your Salary; (iii) a material change in the geographic location at which you provides services to the Company; or (iv) the material breach of this Agreement by the Company. “Good Reason Process” shall mean that (i) you reasonably determine in good faith that a “Good Reason” condition has occurred; (ii) you notify the Company in writing of the first occurrence of the Good Reason condition within 60 days of the first occurrence of such condition; (iii) you cooperate in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason condition continues to exist; and (v) you terminate your employment (without notice) within 60 days after the end of the Cure Period. If the Company cures the Good Reason condition during the Cure Period, Good Reason shall be deemed not to have occurred.
11.5 Your employment hereunder shall also terminate immediately upon your death.
11.6 If your employment with the Company is terminated for any reason, the Company shall pay or provide to you (or to your authorized representative or estate) (i) any Salary earned through the Termination Date (as defined below); (ii) unpaid expense reimbursements (subject to, and in accordance with, paragraph 6 of this Agreement); and (iii) any vested benefits you may have under any employee benefit plan of the Company through the Termination Date, which vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the “Accrued Benefits”).
Severance Pay and Benefits Upon Termination by the Company without Cause or by the Executive for Good Reason outside the Change in Control Period.
11.7 If your employment is terminated on account of your death or by the Company without Cause (being for any reason not covered by clause 11.3), or you terminate your employment for Good Reason (as provided in paragraph 11.4), in either case outside of the Change in Control Period, then the Company shall pay you the Accrued Benefits. In addition, subject to (i) your (or your authorized representative or estate signing, if the termination is due to your death) signing a settlement agreement and a separation agreement and release (together the Settlement Agreements) in a form and manner satisfactory to the Company, which shall include, without limitation, a general release of claims against the Company and all related persons and entities, a reaffirmation of all of your continuing obligations to the Company, including those set forth in paragraphs 14 — 16, and (in the case of the separation agreement and release) and a seven (7) business day revocation period; and (ii) the separation agreement and release becoming irrevocable, all within 60 days after the Termination Date (or such shorter period as set forth in the Settlement Agreements): the Company shall pay you (or your authorized representative or estate if the termination is due to your death) an amount equal to twelve (12) months of your salary as of the Termination Date which payment shall be inclusive of (or reduced by) the value of any salary paid to you during your notice period and/or any payment in lieu of notice made pursuant to clause 11.2 (the “Severance Amount”).
Notwithstanding anything to the contrary in any applicable option agreement or other stock-based award agreement, if the Executive’s employment is terminated pursuant to paragraph 11.5 all time-based stock options and other stock-based awards subject to time-based vesting held by the Executive (the “Time-Based Equity Awards”) shall immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the Termination Date or (ii) the effective date of the Settlement Agreements signed by you (or your authorized representative or estate if the termination is due to your death (the “Accelerated Vesting Date”); provided that any termination or forfeiture of the unvested portion of such Time-Based Equity Awards that would otherwise occur on the Termination Date in the absence of this settlement agreements will be delayed until the effective date of the Settlement Agreements and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Separation Agreement and Release becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Time-Based Equity Awards shall occur during the period between the Executive’s Termination Date and the Accelerated Vesting Date.
Severance Pay and Benefits Upon Termination by the Company without Cause or by the Executive for Good Reason Within the Change in Control Period
11.8 The provisions of this paragraph 11.8 shall apply in lieu of, and expressly supersede, the provisions of paragraph 11.7 regarding severance pay and benefits upon a termination by the Company without Cause or by you for Good Reason if such termination of employment occurs within 12 months after the occurrence of the first event constituting a Change in Control (such period, the “Change in Control Period”). These provisions shall terminate and be of no further force or effect after the Change in Control Period.
(a) Change in Control Period. If during the Change in Control Period your employment is terminated on account of your death or by the Company without Cause (being for any reason not covered by clause 11.3) or you terminate your employment for Good Reason (as provided in paragraph 11.4), then, subject to (i) your signing (or your authorized representative or estate signing, if the termination is due to your death) a settlement agreement and a separation agreement and release (together the
Settlement Agreements) in a form and manner satisfactory to the Company, which shall include, without limitation, a general release of claims against the Company and all related persons and entities, a reaffirmation of all of your continuing obligations to the Company, including those set forth in paragraphs 14 — 16, and (in the case of the separation agreement and release) and a seven (7) business day revocation period; and (ii) the separation agreement and release becoming irrevocable, all within 60 days after the Termination Date (or such shorter period as set forth in the Settlement Agreements):
(i) the Company shall pay you (or your authorized representative or estate if the termination is due to your death) an amount equal to 1.5 times the sum of (A) your annual salary as of the Termination Date (or your annual salary in effect immediately prior to the Change in Control, if higher) plus (B) your target annual performance bonus amount under the Annual Bonus Plan for the then-current year (the “Change in Control Payment”), which payment shall be inclusive of (or reduced by) the value of any salary paid to you during your notice period and/or any payment in lieu of notice made pursuant to clause 11.2 (the “Severance Amount”); and
(ii) notwithstanding anything to the contrary in any applicable option agreement or other stock-based award agreement, all Time-Based Equity Awards shall immediately accelerate and become fully exercisable or nonforfeitable as of the later of (i) the Termination Date or (ii) the Accelerated Vesting Date; provided that any termination or forfeiture of the unvested portion of such Time-Based Equity Awards that would otherwise occur on the Termination Date in the absence of this Agreement will be delayed until the Effective Date of the Settlement Agreements and will only occur if the vesting pursuant to this subsection does not occur due to the absence of the Settlement Agreements becoming fully effective within the time period set forth therein. Notwithstanding the foregoing, no additional vesting of the Time-Based Equity Awards shall occur during the period between your Termination Date and the Accelerated Vesting Date.
(b) Definitions. For purposes of this paragraph 11, the following terms shall have the following meanings:
“Termination Date” means the date on which your employment hereunder terminates.
“Change in Control” shall mean a Sale Event as defined in the Schedule to this Agreement.
12 INDEPENDENT ACTIVITY
You will be permitted to participate as an advisor, consultant, member or board director of other pharma/biotech sector entities from time to time during your employment, which may be industrial, academic or not-for-profit organisations or committees, provided that the time committed to such duties does not exceed 6 days service per year. Any such appointment is subject to the prior approval of the Board such approval not to be unreasonably withheld and must not compete with the business of the Company. You will place the Company’s business in priority over any such independent activity. The Board may at its discretion increase the permitted time commitment to up to 12 days where a new specific opportunity has been identified by you which would give you experience that is considered to be of wider benefit to the Company, again such permission not to be unreasonably withheld and subject to the same other conditions set out above.
13 DISCIPLINARY, DISMISSAL AND GRIEVANCE PROCEDURES
13.1 A copy of the Company’s disciplinary, dismissal and grievance procedures are set out in its employee handbook (the “Employee Handbook”).
13.2 Any grievance concerning your employment should be taken up orally in the first instance with the Chairman. If the grievance is not resolved to your satisfaction, you should then refer it to the Board.
13.3 The Company reserves the right to suspend you on full pay and benefits at any time for a reasonable period to investigate any potential disciplinary matter that it reasonably believes you may be or may have been involved in.
14 OUTSIDE EMPLOYMENT, CONFIDENTIAL INFORMATION, CONFLICTING INTERESTS AND RETURN OF COMPANY PROPERTY
14.1 For the purposes of this paragraph, paragraph 10 above and paragraph 15 below the expression “Confidential Information” shall include, but not be limited to, information which relates to any and all information (whether or not recorded in documentary form or on computer disk or tape), which may be imparted in confidence or which is of a confidential nature or which you may reasonably regard as being confidential or a trade secret, concerning the business, business performance or prospective business, financial information or arrangements, plans or internal affairs of the Company, any Group Company or any of their respective customers including, without prejudice to the generality of the foregoing, all client or customer lists, price sensitive information, technical information, reports, interpretations, forecasts, records, corporate and business plans and accounts, business methods, financial details, projections and targets, remuneration and personnel details, planned products, planned services, marketing surveys, research reports, market share and pricing statistics, budgets, fee levels, computer passwords, the contents of any databases, tables, know how documents or materials, commissions, commission charges, pricing policies and all information about research and development, the Company’s or any Group Company’s suppliers’, customers’ and clients’ names, addresses (including email), telephone, facsimile or other contact numbers and contact names, the nature of their business operations, their requirements for services supplied by the Company or any Group Company and all confidential aspects of their relationship with the Company or any Group Company.
14.2 You shall not, without the prior written consent of the Company, either solely or jointly, directly or indirectly, carry on or be engaged, concerned or interested in any other trade or business, including, but not limited to, carrying on business with the Company’s suppliers or dealers, save
that nothing in this paragraph 14.2 shall prevent you from holding (with the prior written consent of the Company, which shall not be unreasonably delayed or withheld) up to three percent (3%) of the issued equity share capital of any company where those equity shares are listed on a recognised investment exchange (as defined in section 285 of the Financial Services and Markets Act 2000) or traded on the AIM market operated by the London Stock Exchange. Failure to secure advance permission in accordance with this paragraph may result in summary dismissal.
14.3 You will not (except with the prior written consent of the Board) except in the proper course of your duties during the continuance of this Agreement (which for the avoidance of doubt shall include the use of laptops and remote working), or at any time thereafter:
(a) disclose or use for your own or for another’s purpose or benefit any Confidential Information which you may learn while in the employment of the Company except as required by a court of law or any regulatory body or that which may be in or become part of the public domain other than through any act or default on your part;
(b) copy or reproduce in any form or by or on any media or device or allow others access to copy or reproduce any documents (including without limitation letters, facsimiles and memoranda), disks, memory devices, notebooks, tapes or other medium whether or not eye-readable and copies thereof on which Confidential Information may from time to time be recorded or referred to (“Documents”); or
(c) remove or transmit from the Company or any Group Company’s premises any Documents on which Confidential information may from time to time be recorded.
14.4 Upon termination of your employment for any reason by either party, you must immediately return to the Company all Company property including but not limited to documents, papers, records, keys, credit cards, mobile telephones, computer and related equipment, PDA or similar device, security passes, accounts, specifications, drawings, lists, correspondence, catalogues or the like relating to the Company’s business which is in your possession or under your control and you must not take copies of the same without the Company’s express written authority.
15 RESTRICTIVE COVENANTS
15.1 For the purpose of this paragraph the following expressions shall have the following meanings:
“Prospective Customer” shall mean any person, firm, company or other business who was to your knowledge at the Termination Date negotiating with the Company or with any Group Company with a view to dealing with the Company or any Group Company as a customer;
“Restricted Business” means all or any commercial activities carried on or to be carried on by or for the Company and/or any Group Company (including research and development activities) within the fields of research in which it is operating in terms of the field of constrained peptides generally and/or specific drug targets for which the company is developing and/or researching for itself at the time including (without limitation) all work in the field of lead peptide identification and optimisation and pre-clinical development of constrained peptide therapeutics in the twelve (12) month period ending with the Termination Date;
“Restricted Customers” shall mean any person, firm, company or other business who was to your knowledge at any time in the twelve (12) month period ending with the Termination Date a customer of the Company or any Group Company;
“Restricted Period” shall mean the period of six (6) months from the Termination Date; and
“Termination Date” shall mean the date on which your employment under this Agreement terminates either due to you or the Company terminating it in accordance with the terms of the Agreement or in breach of the terms of this Agreement.
15.2 During the course of your employment hereunder you are likely to obtain Confidential Information relating to the business of the Company or any Group Company and personal knowledge and influence over clients, customers and employees of the Company or any Group Company. You hereby agree with the Company that to protect the Company’s and any and all Group Company’s business interests, customer connections and goodwill and the stability of its or their workforce, that you will not during the Restricted Period (and in respect of sub-paragraph 15(f) below only, at any time):
(a) compete with the business of the Company or any Group Company by being directly or indirectly employed or engaged in any capacity by any person, firm or company which engages in or provides Restricted Business to Restricted Customers or Prospective Customers;
(b) compete with the business of the Company or any Group Company either on your own account or for any person, firm or company directly or indirectly by transacting business in competition with the Restricted Business with any Restricted Customer or Prospective Customer of the Company or Group Company and with whom you personally dealt in respect of Restricted Business in the pursuance of the employment hereunder in the twelve (12) months prior to the Termination Date;
(c) compete with the business of the Company or any Group Company either on your own account or for any person, firm or company directly or indirectly in competition with the Restricted Business by soliciting or endeavouring to solicit or entice the business or custom of any Restricted Customer or Prospective Customer and with whom you personally dealt in respect of Restricted Business in the pursuance of the employment hereunder in the twelve (12) months prior to the Termination Date;
(d) either on your own account or for any person, firm or company directly or indirectly solicit or entice away or endeavour to solicit or entice away any director or senior employee of the Company or any Group Company employed in a managerial, scientific or technical role with whom you have had material personal dealings in the twelve (12) months prior to the Termination Date;
(e) from the Termination Date for the purpose of carrying on any trade, or business represent or allow you to be represented or held out as having any present association with the Company or any Group Company; and
(f) from the Termination Date carry on any trade or business whose name incorporates the word Bicycle or any deviation or extension thereof which is likely or which may be confused with the name of the Company or any Group Company.
15.3 While the restrictions set out in paragraph 15.2 above are considered by the parties to be reasonable in all the circumstances, it is agreed that if any one or more of such restrictions shall either taken by itself or themselves together be adjudged to go beyond what is reasonable in all the circumstances for the protection of the legitimate interests of the Company but would be adjudged reasonable if any particular restriction or restrictions were deleted or if any part or parts of the wording thereof were deleted, restricted or limited in a particular manner, then the restrictions set out in paragraph 15.2 above shall apply with such deletions or restrictions or
limitations as the case may be.
15.4 For the avoidance of doubt nothing in this paragraph 15 shall prevent you from having any dealings with any Prospective Customer or Restricted Customer in relation to any business which is not Restricted Businesses, nor from continuing to deal with any Prospective Customer or Restricted Customer where you either have a social or business relationship unconnected to the Company and that relationship does not compete with the Restricted Business.
15.5 The restrictions contained in paragraph 15.2 above are held by the Company for itself and on trust for any other Group Company and shall be enforceable by the Company on their behalf or by any Group Company (at their request). You shall during the employment hereunder enter into direct agreements with any Group Company whereby you will accept restrictions in the same or substantially the same form as those contained in paragraph 15.2 above.
15.6 In the event that the Company exercises its rights and places you on Garden Leave under paragraph 10 above then the Restricted Period shall be reduced by any period/s spent by you on Garden Leave prior to the Termination Date.
15.7 During the Restricted Period you shall provide a copy of the restrictions contained at paragraph 15 above and this paragraph 15 to any employer or prospective employer or any other party with whom you become or will become engaged or provide service or services to.
16 INTELLECTUAL PROPERTY
16.1 For the purpose of this paragraph “IPRs” shall mean copyrights, patents, xxxxx patents, ideas, concepts; innovations, drug formulations, technology, rights in domain names, trade and business names (including goodwill associated with any trademarks or trade or business names) rights in inventions, utility models, rights in knowhow, trademarks, service marks, unregistered design rights, registered design rights, database rights, semi-conductor topography rights and all other intellectual property rights (whether or not registered and including registrations and applications for registration) and all similar rights or forms of protection which may exist anywhere in the world.
16.2 It is contemplated that you may in the course of your employment with the Company create, author or originate (either alone or jointly with others) software, inventions, or improvements, enhancements or modifications to any inventions, technology or software (“Inventions”), or databases, data, information, know how, software, literature, drawings, designs, works, documents, publications and materials (in printed, electronic, or any other media or form) (together with Inventions constituting “Works”).
16.3 You will promptly disclose to the Company full details of any such Inventions and provide further details, explanations and demonstrations as the Company from time to time requests.
16.4 All IPRs subsisting in any Works shall be the exclusive property of the Company.
16.5 To the extent that such IPRs do not vest automatically in the Company by operation of law, you hereby assign to the Company all future copyright, unregistered design rights and database rights, and hereby agree to assign to the Company all other future IPRs, which you may own and which may subsist in any Works for their full term of protection (including any extensions, revivals and renewals) together with the right to xxx and claim remedies for past infringement.
16.6 To the extent permitted by law you hereby irrevocably and unconditionally waive in favour of the Company, its licensees and successors in title, future moral rights (or similar rights existing in any part of the world) you may have in respect of any Works.
16.7 Without prejudice to the generality of paragraph 16.9 below, during your employment with the Company and thereafter, without limit in time, you shall at the request and expense of the Company, promptly assist the Company:
(a) to file, prosecute, obtain and maintain registrations and applications for registration of any IPRs subsisting in, or protecting, any Works; and
(b) to commence and prosecute legal and other proceedings against any third party for infringement of any IPRs subsisting in, or protecting, any Works and to defend any proceedings or claims made by any third party that the use or exploitation of any Works infringes the IPRs or rights of any third party.
16.8 You shall not disclose the subject matter of any Inventions to any person outside the Company without the prior consent of the Company. You acknowledge that any unauthorised disclosure of such subject matter may prevent the Company from obtaining patent or registered intellectual property protection for such Invention.
16.9 Subject to paragraph 16.10 below, during your employment with the Company and thereafter without limit in time you shall at the request and expense of the Company promptly execute and do all acts, matters, documents and things necessary or desirable to give the Company the full benefit of the provision of this paragraph 16.
16.10 Nothing in this paragraph 16 shall be construed, or have the effect of, restricting your rights under sections 39 to 43 (inclusive) of the Patents Xxx 0000 (as amended from time to time).
17 LITIGATION ASSISTANCE
17.1 During the term of your employment and at all times thereafter subject always to your obligations to third parties, you shall furnish such information and proper assistance to the Company or any Group Companies as it or they may reasonably require in connection with the Company’s intellectual property (including without limitation applying for, defending, maintaining and protecting such intellectual property) and in connection with litigation in which it is or they are or may become a party. This obligation on you shall include, without limitation, meeting with the Company or any Group Companies’ legal advisers, providing witness evidence, both in written and oral form, and providing such other assistance that the Company or any Group Companies’ legal advisors in their reasonable opinion determine. The Company shall reimburse you for all reasonable out of pocket expenses incurred by you in furnishing such information and assistance and in the event you are no longer employed by the Company a reasonable daily rate (as agreed between you and the Company for such assistance). Such assistance shall not require you to provide assistance for more than 5 days in any calendar month. For the avoidance of doubt the obligations under this paragraph shall continue notwithstanding the termination of your employment with the Company.
18 COLLECTIVE AGREEMENTS
18.1 There are no collective agreements which directly affect your terms and conditions of employment.
19 DATA PROTECTION
Processing of personal data and our policies
19.1 Information relating to an individual (or from which an individual may be identified) is called “personal data”.
19.2 In processing personal data, we are required to comply with the law on data protection. To help us achieve this, we have produced a privacy notice (“Privacy Notice”). This may be found in the Employee Handbook. You must read this and comply with it in carrying out your work.
Data protection principles
19.3 In complying with the law on data protection, we are required to comply with what are known as data protection principles. These are summarised in our Privacy Notice. In performing your role and carrying out your responsibilities, you must do your best to ensure that we comply with these principles.
19.4 A key element of the data protection principles is the duty to ensure that data is processed securely and protected against unauthorised or unlawful processing or loss. Key elements include the following:
(a) You must ensure that laptops, memory sticks, phones and other mobile devices are password protected and encrypted. You must not take such devices outside the office without encryption. You must take care of them and keep them secure.
(b) You must use strong passwords, changing them when asked and not sharing them with unauthorised colleagues.
(c) You must not access other individuals’ personal data unless in the course of your work.
Data breach — and urgent notification
19.5 If you discover a data breach, you must notify the Chairman or CFO immediately — and, if practicable, within one hour. Depending on context, you may then need to provide further information on the circumstances of the breach.
19.6 A data breach occurs where there is destruction, loss, alteration or unauthorised disclosure of or access to personal data which is being held, stored, transmitted or processed in any way. For example, there is a data breach if our servers are hacked or if you lose a laptop or USB stick or send an email to the wrong person by mistake.
19.7 Failure to notify a breach or to provide information as set out above will be treated seriously and disciplinary action may be taken.
Why we process personal data
19.8 For information on the nature of the data we process, why we process it, the legal basis for processing and related matters, please refer to our Privacy Notice. In summary:
(a) We process personal data relating to you for the purposes of our business including management, administrative, employment and legal purposes.
(b) We monitor our premises and the use of our communication facilities, including using CCTV cameras, monitoring compliance with our data and IT policies, and where non-compliance is suspected, looking in a more targeted way.
19.9 The summary above is for information only. We do not, in general, rely on your consent as a legal basis for processing. Agreeing the terms of this Agreement will not constitute your giving consent to our processing of your data.
19.10 We reserve the right to amend the documents referred to above from time to time.
20 THIRD PARTY RIGHTS
20.1 Save in respect of any rights conferred by this Agreement on any Group Company (which such Group Company shall be entitled to enforce), a person who is not a party to this Agreement may
not under the Contracts (Rights of Third Parties) Xxx 0000 enforce any of the terms contained within this Agreement.
21 GROUP COMPANIES
21.1 In this Agreement “Group Company” means a subsidiary or affiliate and any other company which is for the time being a holding company of the Company or another subsidiary or affiliate of any such holding company as defined by the Companies Xxx 0000 (as amended) and “Group Companies” will be interpreted accordingly.
22 ENTIRE AGREEMENT
22.1 These terms and conditions constitute the entire agreement between the parties and supersede any other agreement whether written or oral previously entered into.
23 JURISDICTION AND CHOICE OF LAW
23.1 This Agreement shall be governed by and interpreted in accordance with the laws of England and Wales and the parties to this Agreement submit to the exclusive jurisdiction of the Courts of England and Wales in relation to any claim, dispute or matter arising out of or relating to this Agreement.
24 NOTICES
24.1 Any notices with respect to this Agreement shall be in writing and shall be deemed given if delivered personally (upon receipt), sent by facsimile (which is confirmed) or sent by first class post addressed, in the case of the Company, to its registered office and in your case, addressed to your address last known to the Company.
Schedule
Shareholder Value Realisation Bonus - Definitions
Defined terms in paragraph 4.6 shall have the following meanings unless otherwise specified:
|
A Ordinary Conversion Rate: |
|
the conversion rate of one A Ordinary Share into one Ordinary Share, subject to adjustment in accordance with Article 8.7 of the Articles; |
|
|
|
|
|
A Ordinary Shares: |
|
the A ordinary shares of £0.01 each in the capital of BTL; |
|
|
|
|
|
A Ordinary Shareholders: |
|
the holders of the A Ordinary Shares; |
|
|
|
|
|
Acting in Concert: |
|
has the meaning given to it in The City Code on Takeovers and Mergers published by the Panel on Takeovers and Mergers (as amended from time to time); |
|
|
|
|
|
Articles: |
|
the Articles of Association of BTL from time to time; |
|
|
|
|
|
As Converted Basis: |
|
in reference to any calculation or number, means that such calculation shall be made, or number determined, on the basis that each Preferred Share is equivalent to such number of Ordinary Shares as is converted in accordance with the Conversion Rate and, if applicable, adjusted in accordance with Article 8.7; |
|
|
|
|
|
B Ordinary Conversion Rate: |
|
the conversion rate of one B Ordinary Share into one Ordinary Share, subject to adjustment in accordance with Article 8.7 of the Articles; |
|
|
|
|
|
B Ordinary Shares: |
|
the B Ordinary shares of £0.01 each in the capital of BTL; |
|
|
|
|
|
B Ordinary Shareholders: |
|
the holders of the B Ordinary Shares; |
|
|
|
|
|
BTL: |
|
Bicycle Therapeutics Limited, a company incorporated in England and Wales under registered number 11036004; |
|
|
|
|
|
Business Sale: |
|
(a) a Subsidiary Share Sale; and |
|
|
|
|
|
Controlling Interest: |
|
an interest in shares giving to the holder or holders control of the relevant company within the meaning of section 1124 of the Corporation Tax Xxx 0000; |
|
|
|
|
|
Conversion Rate: |
|
the A Ordinary Conversion Rate or the B Ordinary Conversion Rate (as |
|
|
|
applicable); |
|
|
|
|
|
IPO: |
|
the admission of all or any of the Shares or securities representing those shares (including without limitation American depositary receipts, American depositary shares and/or other instruments) to or the grant of permission by any like authority for the same to be traded or quoted on Nasdaq or on the Official List of the United Kingdom Listing Authority or on the AIM Market operated by the London Stock Exchange Plc or any other recognised investment exchange (as defined in section 285 of the Financial Services and Markets Act 2000); |
|
|
|
|
|
Ordinary Shares: |
|
the ordinary shares of £0.01 each in the capital of BTL; |
|
|
|
|
|
Ordinary Shareholders: |
|
the holders from time to time of the Ordinary Shares; |
|
|
|
|
|
Preferred Majority: |
|
the Preferred Shareholders holding more than fifty percent (50%) of the number of Ordinary Shares held by Preferred Shareholders as at the date on which the Articles were adopted on an As Converted Basis; |
|
|
|
|
|
Preferred Shareholders: |
|
the B Ordinary Shareholders, the A Ordinary Shareholders and any other class of preferred shares in the capital of BTL from time to time; |
|
|
|
|
|
Remuneration Committee |
|
the Remuneration Committee of the board of BTL from time to time; |
|
|
|
|
|
Sale Event: |
|
shall mean any of the following: |
|
|
|
|
|
Sale Event Date: |
|
the completion of the agreement to effect the Business Sale or Share Sale as appropriate; |
|
|
|
|
|
Sale Event Proceeds: |
|
in the case of a Business Sale other than a Subsidiary Share Sale, Surplus Assets and in the case of a Share Sale and a Subsidiary Share Sale, Sale Proceeds; |
|
|
|
|
|
Sale Proceeds: |
|
the consideration payable (including deferred consideration) whether in cash or otherwise to those Shareholders selling Shares under a Share Sale or to BTL selling shares in any Subsidiary under a Subsidiary Share Sale, in each case net of any transaction costs, such amount to be determined at the sole discretion of the Remuneration Committee of the Board of BTL; |
|
|
|
|
|
Shareholder: |
|
any holder of any Shares; |
|
|
|
|
|
Shares: |
|
the Ordinary Shares, the A Ordinary Shares and B Ordinary Shares and any |
|
|
|
other shares in the capital of BTL from time to time; |
|
|
|
|
|
Share Sale: |
|
a sale or other transfer of the whole or any part of the issued share capital of BTL on arm’s length terms to any person (or any merger or scheme of arrangement resulting in any persons holding Shares) and resulting in that person together with all persons (if any) Acting in Concert with such person together holding a Controlling Interest in BTL; |
|
|
|
|
|
Subsidiary: |
|
shall have the meanings given to the term in the Companies Xxx 0000; |
|
|
|
|
|
Subsidiary Share Sale: |
|
a sale or other transfer of the whole or any part of the issued share capital of a Subsidiary by BTL on arm’s length terms to any person which is not a member of the Group (or any merger or scheme of arrangement resulting in any such persons holding shares) and resulting in that person together with all persons (if any) Acting in Concert with such person together holding a Controlling Interest in the Subsidiary; and |
|
|
|
|
|
Surplus Assets: |
|
the surplus assets of BTL remaining after the payment (or other satisfaction) of its liabilities, such amount to be determined at the sole discretion of the Remuneration Committee of the Board of BTL. |
THIS AGREEMENT has been executed and delivered as a deed by or on behalf of the parties on the date written at the top of page 1.
Executed as a Deed by BicycleTx Limited acting by a director:
|
/s/ Xxxxxx Xxxxxxx |
(Director) |
| |
|
|
| ||
|
in the presence of: |
| ||
|
|
| ||
|
/s/ Xxxxx Xxxxxx |
|
| |
|
Witness Name: Xxxxx Xxxxxx |
| ||
|
|
| ||
|
Witness Address: |
00 Xxxxxx Xxxxx, |
| |
Executed as a Deed by Xxxxx Xxx:
|
/s/ Xxxxx Xxx |
(Xxxxx Xxx) |
| |
|
|
| ||
|
in the presence of: |
| ||
|
|
| ||
|
/s/ Xxxxx Xxxxxx |
|
| |
|
Witness Name: Xxxxx Xxxxxx |
| ||
|
|
| ||
|
Witness Address: |
00 Xxxxxx Xxxxx, |
| |
